$BXMT
BLACKSTONE MORTGAGE TRUST, INC.

2023 Q2 Form 10-Q Financial Statement

#000106163023000027 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $521.9M $491.4M
YoY Change 83.97% 109.61%
Cost Of Revenue $377.4M $348.2M
YoY Change 130.54% 180.39%
Gross Profit $144.5M $143.1M
YoY Change 20.44% 29.85%
Gross Profit Margin 27.69% 29.13%
Selling, General & Admin $10.96M $10.93M
YoY Change -1.4% -3.65%
% of Gross Profit 7.58% 7.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $13.02M $12.86M
YoY Change 4.94% 4.09%
Operating Profit $131.5M $130.3M
YoY Change 22.22% 33.1%
Interest Expense $344.5M $317.2M
YoY Change 152.2% 214.99%
% of Operating Profit 262.0% 243.49%
Other Income/Expense, Net
YoY Change
Pretax Income $103.7M $120.4M
YoY Change 9.61% 19.96%
Income Tax $1.202M $1.900M
% Of Pretax Income 1.16% 1.58%
Net Earnings $101.7M $117.8M
YoY Change 9.01% 18.13%
Net Earnings / Revenue 19.48% 23.96%
Basic Earnings Per Share $0.59 $0.68
Diluted Earnings Per Share $0.56 $0.67
COMMON SHARES
Basic Shares Outstanding 172.3M shares 172.3M shares
Diluted Shares Outstanding 180.9M shares 180.9M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $482.9M $515.8M
YoY Change 70.27% 66.7%
Cash & Equivalents $482.9M $515.8M
Short-Term Investments
Other Short-Term Assets $49.68M $99.84M
YoY Change -80.38% 321.79%
Inventory
Prepaid Expenses
Receivables $188.8M $182.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $721.4M $797.6M
YoY Change 9.26% 86.34%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.14B $24.59B
YoY Change -2.59% 4.01%
TOTAL ASSETS
Total Short-Term Assets $721.4M $797.6M
Total Long-Term Assets $24.14B $24.59B
Total Assets $24.86B $25.39B
YoY Change -2.28% 5.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.717M $8.588M
YoY Change 10.36% -21.96%
Accrued Expenses $105.4M $95.04M
YoY Change 27.93% 55.89%
Deferred Revenue
YoY Change
Short-Term Debt $16.27M $15.75M
YoY Change 92.93% 151.82%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $237.2M $226.2M
YoY Change 16.11% 23.07%
LONG-TERM LIABILITIES
Long-Term Debt $20.00B $20.54B
YoY Change -2.67% 6.94%
Other Long-Term Liabilities $56.78M $57.05M
YoY Change 129.81% 776.11%
Total Long-Term Liabilities $20.06B $20.60B
YoY Change -2.51% 7.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $237.2M $226.2M
Total Long-Term Liabilities $20.06B $20.60B
Total Liabilities $20.32B $20.82B
YoY Change -2.21% 7.35%
SHAREHOLDERS EQUITY
Retained Earnings -$963.4M -$958.1M
YoY Change 18.72% 19.91%
Common Stock $5.493B $5.485B
YoY Change 0.94% 0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.541B $4.535B
YoY Change
Total Liabilities & Shareholders Equity $24.86B $25.39B
YoY Change -2.28% 5.47%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $101.7M $117.8M
YoY Change 9.01% 18.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $127.9M $110.2M
YoY Change 36.79% 22.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $582.1M $156.5M
YoY Change -133.93% -109.27%
Cash From Investing Activities $582.1M $156.5M
YoY Change -133.93% -109.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -744.8M -$43.73M
YoY Change -146.43% -103.21%
NET CHANGE
Cash From Operating Activities 127.9M $110.2M
Cash From Investing Activities 582.1M $156.5M
Cash From Financing Activities -744.8M -$43.73M
Net Change In Cash -34.75M $223.0M
YoY Change 92.3% -193.47%
FREE CASH FLOW
Cash From Operating Activities $127.9M $110.2M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001061630
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-14788
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Blackstone Mortgage Trust, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-6181186
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
345 Park Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10154
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
655-0220
CY2023Q1 dei Security12b Title
Security12bTitle
Class A common stock,
CY2023Q1 dei Trading Symbol
TradingSymbol
BXMT
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172286354 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515808000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291340000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24896364000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
310086000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
370902000 usd
CY2023Q1 us-gaap Assets
Assets
25385667000 usd
CY2022Q4 us-gaap Assets
Assets
25353985000 usd
CY2023Q1 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
14029486000 usd
CY2022Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
13528164000 usd
CY2023Q1 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2664208000 usd
CY2022Q4 bxmt Securitized Debt Obligations Net
SecuritizedDebtObligationsNet
2664010000 usd
CY2023Q1 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
817444000 usd
CY2022Q4 bxmt Asset Specific Debt Agreements Net
AssetSpecificDebtAgreementsNet
942503000 usd
CY2023Q1 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
229003000 usd
CY2022Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
224232000 usd
CY2023Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2111232000 usd
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
2114549000 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
395461000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
395166000 usd
CY2023Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
294888000 usd
CY2022Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
514257000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
283246000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
426904000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
20824968000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
20809785000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172284118 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172284118 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171695985 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171695985 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1723000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1717000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5483740000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5475804000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7828000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10022000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-958064000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-968749000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4535227000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4518794000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
25472000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
25406000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4560699000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4544200000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25385667000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25353985000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
491384000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
234432000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
317197000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
100714000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
174187000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
133718000 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
31050000 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
23486000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12865000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12360000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
43915000 usd
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
35846000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
9823000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-2537000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120449000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100409000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1893000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
146000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
799000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
576000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180869409 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175602905 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
21858000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-45222000 usd
CY2023Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-24052000 usd
CY2022Q1 bxmt Other Comprehensive Income Realized And Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeRealizedAndUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
45514000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2194000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
116362000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
100555000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
799000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
576000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
115563000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
99979000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4618711000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
52154000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
8477000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
246000 usd
CY2022Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
173000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q1 us-gaap Dividends
Dividends
105801000 usd
CY2022Q1 bxmt Cash Contributions From Joint Venture Partners That Increase Equity
CashContributionsFromJointVenturePartnersThatIncreaseEquity
5040000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9241000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4669837000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4544200000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7492000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
287000 usd
CY2023Q1 bxmt Adjustments To Additional Paid In Capital Deferred Compensation
AdjustmentsToAdditionalPaidInCapitalDeferredCompensation
163000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2194000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2023Q1 us-gaap Dividends
Dividends
107072000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
733000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4560699000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
118556000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
100263000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7655000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8650000 usd
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
21755000 usd
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
18573000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14811000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10530000 usd
CY2023Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
9823000 usd
CY2022Q1 bxmt Increase Decrease In Current Expected Credit Loss Reserve
IncreaseDecreaseInCurrentExpectedCreditLossReserve
-2537000 usd
CY2023Q1 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
0 usd
CY2022Q1 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-21000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-541000 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-684000 usd
CY2023Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
8948000 usd
CY2022Q1 bxmt Realized Gains Losses On Derivative Financial Instruments Net
RealizedGainsLossesOnDerivativeFinancialInstrumentsNet
2437000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10422000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10319000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-20932000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3858000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110173000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90098000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
369812000 usd
CY2022Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
2924418000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
562072000 usd
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
1179632000 usd
CY2023Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
2850000 usd
CY2022Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
29775000 usd
CY2023Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
5370000 usd
CY2022Q1 bxmt Proceeds From Derivative Instruments In Investing Activities
ProceedsFromDerivativeInstrumentsInInvestingActivities
28981000 usd
CY2023Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
136689000 usd
CY2022Q1 bxmt Payments For Derivative Instruments In Investing Activities
PaymentsForDerivativeInstrumentsInInvestingActivities
2720000 usd
CY2023Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
79970000 usd
CY2022Q1 bxmt Payments For Collateral Deposits Related To Derivatives
PaymentsForCollateralDepositsRelatedToDerivatives
0 usd
CY2023Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
172710000 usd
CY2022Q1 bxmt Proceeds From Collateral Deposits Related To Derivatives
ProceedsFromCollateralDepositsRelatedToDerivatives
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
156531000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1688750000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
947245000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2093695000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
521407000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1205929000 usd
CY2023Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
1807000 usd
CY2022Q1 bxmt Repayments For Collateralized Loan Obligations
RepaymentsForCollateralizedLoanObligations
0 usd
CY2023Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
78496000 usd
CY2022Q1 bxmt Proceeds From Asset Specific Debt Agreements
ProceedsFromAssetSpecificDebtAgreements
147726000 usd
CY2023Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
206300000 usd
CY2022Q1 bxmt Repayments Of Asset Specific Debt Agreements
RepaymentsOfAssetSpecificDebtAgreements
78659000 usd
CY2023Q1 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
0 usd
CY2022Q1 bxmt Proceeds From Sale Of Loan Participation
ProceedsFromSaleOfLoanParticipation
245278000 usd
CY2023Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
5499000 usd
CY2022Q1 bxmt Repayments Of Secured Term Loans
RepaymentsOfSecuredTermLoans
3435000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
294000000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
220000000 usd
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
64650000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7265000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11616000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5040000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
733000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
9241000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
52155000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
106455000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
104271000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43725000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1360093000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
222979000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-238559000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
291340000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551154000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1489000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3170000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
515808000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309425000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
318185000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
81984000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
900000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
161000 usd
CY2023Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
106816000 usd
CY2022Q1 bxmt Dividends Declared And Not Paid
DividendsDeclaredAndNotPaid
105576000 usd
CY2023Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
19756000 usd
CY2022Q1 bxmt Loan Principal Payments Held By Servicer
LoanPrincipalPaymentsHeldByServicer
4635000 usd
CY2023Q1 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P2Y10M24D
CY2022 bxmt Mortgage Loan On Real Estate Final Maturity Term
MortgageLoanOnRealEstateFinalMaturityTerm
P3Y1M6D
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
ORGANIZATION <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">References herein to “Blackstone Mortgage Trust,” “Company,” “we,” “us” or “our” refer to Blackstone Mortgage Trust, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blackstone Mortgage Trust is a real estate finance company that originates senior loans collateralized by commercial real estate in North America, Europe, and Australia. Our portfolio is composed primarily of loans secured by high-quality, institutional assets in major markets, sponsored by experienced, well-capitalized real estate investment owners and operators. These senior loans are capitalized by accessing a variety of financing options, including borrowing under our credit facilities, issuing CLOs or single-asset securitizations, and syndicating senior loan participations, depending on our view of the most prudent financing option available for each of our investments. We are not in the business of buying or trading securities, and the only securities we own are the retained interests from our securitization financing transactions, which we have not financed. We are externally managed by BXMT Advisors L.L.C., or our Manager, a subsidiary of Blackstone Inc., or Blackstone, and are a real estate investment trust, or REIT, traded on the New York Stock Exchange, or NYSE, under the symbol “BXMT.” Our principal executive offices are located at 345 Park Avenue, 24th Floor, New York, New York 10154. </span></div>We conduct our operations as a REIT for U.S. federal income tax purposes. We generally will not be subject to U.S. federal income taxes on our taxable income to the extent that we annually distribute all of our net taxable income to stockholders and maintain our qualification as a REIT. We also operate our business in a manner that permits us to maintain an exclusion from registration under the Investment Company Act of 1940, as amended. We are organized as a holding company and conduct our business primarily through our various subsidiaries.
CY2017Q4 bxmt Joint Venture Capital Contribution Percentage
JointVentureCapitalContributionPercentage
0.85
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may ultimately differ materially from those estimates.</span></div>
CY2023Q1 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenue Recognition </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest income from our loans receivable portfolio is recognized over the life of each investment using the effective interest method and is recorded on the accrual basis. Recognition of fees, premiums, and discounts associated with these investments is deferred and recorded over the term of the loan as an adjustment to yield. Income accrual is generally suspended for loans at the earlier of the date at which payments become 90 days past due or when, in our opinion, recovery of income and principal becomes doubtful. Interest received is then recorded as a reduction in the outstanding principal balance until accrual is resumed when the loan becomes contractually current and performance is demonstrated to be resumed. In addition, for loans we originate, the related origination expenses are deferred and recognized as a component of interest income, however expenses related to loans we acquire are included in general and administrative expenses as incurred.</span></div>
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
446700000 usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
459600000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25020489000 usd
CY2023Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
199 securityloan
CY2022Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 securityloan
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25020489000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25160343000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25160343000 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-142463000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2023Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
369812000 usd
CY2023Q1 bxmt Financing Receivable New Issue
FinancingReceivableNewIssue
369812000 usd
CY2023Q1 bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
592361000 usd
CY2023Q1 bxmt Financing Receivable Sale And Collection Of Finance Receivables
FinancingReceivableSaleAndCollectionOfFinanceReceivables
592361000 usd
CY2023Q1 bxmt Financing Receivable Gain Loss On Foreign Currency Translation
FinancingReceivableGainLossOnForeignCurrencyTranslation
82695000 usd
CY2023Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Gain Loss On Foreign Currency Translation
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountGainLossOnForeignCurrencyTranslation
567000 usd
CY2023Q1 bxmt Financing Receivable Before Allowance For Credit Loss Fee And Loan In Process Gain Loss On Foreign Currency Translation
FinancingReceivableBeforeAllowanceForCreditLossFeeAndLoanInProcessGainLossOnForeignCurrencyTranslation
82128000 usd
CY2023Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
2850000 usd
CY2023Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount New Issues
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountNewIssues
2850000 usd
CY2023Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
21755000 usd
CY2023Q1 bxmt Financing Receivable Unamortized Loan Fee Cost And Purchase Premium Discount Amortization
FinancingReceivableUnamortizedLoanFeeCostAndPurchasePremiumDiscountAmortization
21755000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
25020489000 usd
CY2023Q1 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-124125000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24896364000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2023Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
199 securityloan
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24896364000 usd
CY2023Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26742669000 usd
CY2023Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23631557000 usd
CY2023Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2023Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
199 securityloan
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24896364000 usd
CY2023Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26742669000 usd
CY2023Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23631557000 usd
CY2023Q1 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2023Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1700000000 usd
CY2023Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1700000000 usd
CY2023Q1 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
822900000 usd
CY2023Q1 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
229500000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336600000 usd
CY2022Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 securityloan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2022Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 securityloan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
2.9
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 bxmt Financing Receivable Percentage Of Loan Portfolio
FinancingReceivablePercentageOfLoanPortfolio
1
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
950300000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
224700000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326100000 usd
CY2023Q1 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
199 securityloan
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
24896364000 usd
CY2023Q1 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26742669000 usd
CY2023Q1 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23631557000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2022Q4 bxmt Financing Receivable Number Of Loans
FinancingReceivableNumberOfLoans
203 securityloan
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
25017880000 usd
CY2022Q4 bxmt Financing Receivable Loans Exposure Amount
FinancingReceivableLoansExposureAmount
26810281000 usd
CY2022Q4 bxmt Financing Receivable Excluding Accrued Interest Net Loans Exposure Amount
FinancingReceivableExcludingAccruedInterestNetLoansExposureAmount
23659183000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1700000000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2023Q1 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1700000000 usd
CY2023Q1 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
822900000 usd
CY2023Q1 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
229500000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336600000 usd
CY2022Q4 bxmt Loan Exposure Amount Including Non Consolidated Senior Interests
LoanExposureAmountIncludingNonConsolidatedSeniorInterests
1600000000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Asset Specific Debt
NetLoanExposureAmountAssetSpecificDebt
950300000 usd
CY2022Q4 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
224700000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326100000 usd
CY2023Q1 bxmt Weighted Average Risk Rating
WeightedAverageRiskRating
2.9
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
10454000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
124679000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
-2458000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
122221000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease
10500000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336600000 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
18300000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
336591000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24559773000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
326137000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
24691743000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
310086000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
181951000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
189569000 usd
CY2023Q1 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
98778000 usd
CY2022Q4 bxmt Loan Portfolio Payments Held By Our Third Party Loan Servicer
LoanPortfolioPaymentsHeldByOurThirdPartyLoanServicer
68489000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
16907000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
7349000 usd
CY2023Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
10370000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103110000 usd
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1063000 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1067000 usd
CY2023Q1 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
1017000 usd
CY2022Q4 bxmt Accounts Receivable Net Current And Other Assets Current
AccountsReceivableNetCurrentAndOtherAssetsCurrent
1318000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
370902000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
106816000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
106455000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
63991000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
80263000 usd
CY2023Q1 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
43502000 usd
CY2022Q4 bxmt Secured Debt Repayments Pending Servicer Remittance
SecuredDebtRepaymentsPendingServicerRemittance
60585000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
31050000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
33830000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
15749000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
16380000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
13550000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
119665000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
8588000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
9726000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
283246000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
426904000 usd
CY2023Q1 bxmt Debt Instrument Covenant Requirement On Consolidated Tangible Net Worth Minimum
DebtInstrumentCovenantRequirementOnConsolidatedTangibleNetWorthMinimum
3600000000 usd
CY2023Q1 bxmt Debt Instrument Covenant Maximum Percentage Of Cash Liquidity On Recourse Indebtedness
DebtInstrumentCovenantMaximumPercentageOfCashLiquidityOnRecourseIndebtedness
0.05
CY2023Q1 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
39800000 usd
CY2022 bxmt Interest Expense Secured Debt
InterestExpenseSecuredDebt
87600000 usd
CY2023Q1 us-gaap Share Price
SharePrice
17.85
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-24052000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
16907000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
7349000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
13550000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
119665000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
45510000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
4000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
100700000 usd
CY2023Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
10400000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
103100000 usd
CY2023Q1 bxmt Stock Shares Authorized
StockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172106593 shares
CY2021Q4 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
168543370 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1377 shares
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1675639 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
481724 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
427634 shares
CY2023Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
10903 shares
CY2022Q1 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
7063 shares
CY2023Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
172600597 shares
CY2022Q1 bxmt Common Stock Shares Outstanding Including Stock Equivalents
CommonStockSharesOutstandingIncludingStockEquivalents
170653706 shares
CY2023Q1 bxmt Deferred Stock Units
DeferredStockUnits
316479 shares
CY2022Q1 bxmt Deferred Stock Units
DeferredStockUnits
370635 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1377 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
639 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
1377 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
639 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.62
CY2023Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
256000 usd
CY2022Q1 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
225000 usd
CY2023Q1 us-gaap Dividends
Dividends
107072000 usd
CY2022Q1 us-gaap Dividends
Dividends
105801000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
117757000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
99687000 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
3556000 usd
CY2022Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2400000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
121313000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
102087000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172598349 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169254059 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8271060 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6348846 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180869409 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175602905 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7800000 usd
CY2023Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
235700000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-227900000 usd
CY2023Q1 bxmt Debt Instrument Amortization Percentage
DebtInstrumentAmortizationPercentage
0.010
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10000000 usd
CY2022Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
259800000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-249800000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
3279000 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
2698000 usd
CY2023Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1931000 usd
CY2022Q1 bxmt General And Administrative Operating And Other Costs
GeneralAndAdministrativeOperatingAndOtherCosts
1012000 usd
CY2023Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
5210000 usd
CY2022Q1 bxmt Core General And Administrative Expenses
CoreGeneralAndAdministrativeExpenses
3710000 usd
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
7492000 usd
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
8477000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
173000 usd
CY2023Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
7655000 usd
CY2022Q1 bxmt Non Cash And Legacy Compensation Expenses
NonCashAndLegacyCompensationExpenses
8650000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12865000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12360000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1900000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
146000 usd
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
25875000 shares
CY2023Q1 bxmt Operating Loss Carryforwards Limitations On Use Annual Limitation
OperatingLossCarryforwardsLimitationsOnUseAnnualLimitation
2000000.0 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
159000000.0 usd
CY2023Q1 bxmt Number Of Current Benefit Plans
NumberOfCurrentBenefitPlans
2 plan
CY2023Q1 bxmt Number Of Benefit Plans
NumberOfBenefitPlans
9 plan
CY2023Q1 bxmt Number Of Expired Benefit Plans
NumberOfExpiredBenefitPlans
7 plan
CY2023Q1 bxmt Securitized Debt Obligations Excluded From Contractual Obligations
SecuritizedDebtObligationsExcludedFromContractualObligations
2700000000 usd
CY2023Q1 bxmt Nonconsolidated Securitized Debt Excluded From Contractual Obligations
NonconsolidatedSecuritizedDebtExcludedFromContractualObligations
1700000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
515808000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
291340000 usd
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
25020489000 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
25160343000 usd
CY2023Q1 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2671734000 usd
CY2022Q4 bxmt Securitized Debt Obligations Net Face Amount
SecuritizedDebtObligationsNetFaceAmount
2673541000 usd
CY2023Q1 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
822873000 usd
CY2022Q4 bxmt Asset Specific Debt Gross
AssetSpecificDebtGross
950278000 usd
CY2023Q1 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
229468000 usd
CY2022Q4 bxmt Participating Mortgage Loans Participation Liabilities Principal Amount
ParticipatingMortgageLoansParticipationLiabilitiesPrincipalAmount
224744000 usd
CY2023Q1 bxmt Net Loan Exposure Amount Loan Participations Sold
NetLoanExposureAmountLoanParticipationsSold
229500000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
367233000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3402778000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1878987000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6250807000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4083966000 usd
CY2023Q1 bxmt Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1742256000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
17726027000 usd
CY2023Q1 bxmt Board Of Directors Number Of Members
BoardOfDirectorsNumberOfMembers
9 director
CY2023Q1 bxmt Number Of Directors Eligible For Annual Compensation
NumberOfDirectorsEligibleForAnnualCompensation
6 director
CY2023Q1 bxmt Number Of Directors Not Eligible For Compensation
NumberOfDirectorsNotEligibleForCompensation
3 director

Files In Submission

Name View Source Status
0001061630-23-000027-index-headers.html Edgar Link pending
0001061630-23-000027-index.html Edgar Link pending
0001061630-23-000027.txt Edgar Link pending
0001061630-23-000027-xbrl.zip Edgar Link pending
bxmt-20230331.htm Edgar Link pending
bxmt-20230331.xsd Edgar Link pending
bxmt-20230331_g1.gif Edgar Link pending
bxmt-20230331_g2.jpg Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
bxmt-20230331_cal.xml Edgar Link unprocessable
bxmt-20230331_def.xml Edgar Link unprocessable
bxmt-20230331_lab.xml Edgar Link unprocessable
bxmt-20230331_pre.xml Edgar Link unprocessable
bxmt-20230331_htm.xml Edgar Link completed
exhibit991.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable